01 1Heraeus Precious Metals GmbH & Co. KG
01 1Hypericin
01 1Germany
NDC Package Code : 54875-0015
Start Marketing Date : 2015-08-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
34
PharmaCompass offers a list of Hyperoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyperoside manufacturer or Hyperoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyperoside manufacturer or Hyperoside supplier.
PharmaCompass also assists you with knowing the Hyperoside API Price utilized in the formulation of products. Hyperoside API Price is not always fixed or binding as the Hyperoside Price is obtained through a variety of data sources. The Hyperoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Hyperosid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hyperosid, including repackagers and relabelers. The FDA regulates Hyperosid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hyperosid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hyperosid supplier is an individual or a company that provides Hyperosid active pharmaceutical ingredient (API) or Hyperosid finished formulations upon request. The Hyperosid suppliers may include Hyperosid API manufacturers, exporters, distributors and traders.
click here to find a list of Hyperosid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hyperosid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hyperosid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hyperosid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hyperosid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hyperosid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hyperosid suppliers with NDC on PharmaCompass.
We have 1 companies offering Hyperosid
Get in contact with the supplier of your choice:
